Skip to main content

Day: August 10, 2022

Alkaline Fuel Cell Power Announces Development of Fuel Cells for Off-Grid and Back-Up Generator Markets

Written by Customer Service on . Posted in Public Companies.

Figure 1 Image 1TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) — Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB: ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (“AFCP” or the “Company”), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to announce that the Company is supplementing the ongoing development of our 4 kW Combined Heat and Power (“CHP”) fuel cell by developing a range of fuel cells that target more immediate revenue opportunities within the off-grid and back-up generator markets. “A number of global pressures are driving rapid growth and accelerating the revenue potential of the generator market at a pace that exceeds the mass home market, and AFCP is ideally positioned to use our cost-effective alkaline technology to meet this growing demand,” commented Frank...

Continue reading

Post Holdings Announces Pricing of Convertible Senior Notes Offering

Written by Customer Service on . Posted in Public Companies.

ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST) (the “Company” or “Post”) today announced the pricing of its previously announced offering of the Company’s 2.50% convertible senior notes maturing in 2027 (the “Notes”) to eligible purchasers. In addition, the offering size was increased from $400.0 million to $500.0 million in aggregate principal amount of the Notes. Post also granted the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days beginning on, and including, the date the Notes are first issued, up to an additional $75.0 million in aggregate principal amount of the Notes. The issuance and sale of the Notes are expected to settle on August 12, 2022, subject to customary closing conditions. The Notes will be unsecured, senior obligations of the Company...

Continue reading

LATAM Receives US Court and Shareholder Approval on Plan of Reorganization, Secures Exit Financing and Moves Forward With Plan Implementation Requirements

Written by Customer Service on . Posted in Public Companies.

Santiago, Chile, Aug. 09, 2022 (GLOBE NEWSWIRE) — LATAM Group announced today its consolidated financial results for the second quarter of the year, which reflect a gradual recovery of the operation, reaching a consolidated capacity (measured in ASK) of 72.6% compared to 2019 levels, which in turn represents more than double the capacity of the same quarter of 2021, growing by 135.2%. This recovery of capacity is mainly explained by the solidity of the domestic markets in Brazil, Colombia and Ecuador, in addition to the recovery of international operations, and takes place in a context marked by a sharp increase in fuel prices. During the period, the group’s total operating revenues reached US$2.226 billion, 6.1% less than in 2019, but showed an increase of 150.5% compared to last year. In turn, total operating expenses increased...

Continue reading

UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Revenue Up 3% to $14.0 million, driven by new customer and program launches Increase in breadth and scope of brand deal size represents further momentum in the validation of our value proposition Generated $4.4 million in cash flow from operations during the first half of 2022ROCHESTER, Mich., Aug. 09, 2022 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, reported results for the three months ended June 30, 2022. Quarterly comparisons are to the same year-ago period.  Rolling Twelve Months EndedJune 30,Key Performance Indicators (KPIs)*   2022       2021  Average revenue per top 20 pharmaceutical manufacturer $ 2,389,969     $ 2,361,254  Percent of top 20 pharmaceutical manufacturers that are customers   95 %     85 %Percent...

Continue reading

PhenixFIN Corporation Announces Fiscal Third Quarter 2022 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) — PhenixFIN Corporation (NASDAQ: PFX) (the “Company”), a publicly traded business development company, today announced its financial results for the fiscal third quarter of 2022. HighlightsDuring the third quarter total investment income of $3.7 million; net investment income of $0.2 million Net asset value (NAV) of $129.1 million, or $58.74 per share as of June 30, 2022, vs. $57.08 per share as of September 30, 2021 Weighted average yield to maturity of 9.09% on debt investments FlexFIN continues to grow with over $40 million allocated to the businessDavid Lorber, Chief Executive Officer of the Company, stated: “During the third quarter the portfolio performed relatively well given the market environment as we continued generating positive Net Investment Income. While during...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.